Novocure
NVCR
#4387
Rank
$1.63 B
Marketcap
Jersey
Country
$15.30
Share price
0.39%
Change (1 day)
-81.34%
Change (1 year)
Categories

P/E ratio for Novocure (NVCR)

P/E ratio as of February 2024 (TTM): -8.19

According to Novocure 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.19355. At the end of 2022 the company had a P/E ratio of -83.4.

P/E ratio history for Novocure from 2015 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-83.4-37.83%
2021-134-115.5%
2020865-182.14%
2019< -10002102.4%
2018-47.865.74%
2017-28.9469.79%
2016-5.06-68.62%
2015-16.1

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-0.4903-94.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.69-67.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
-0.6787-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-8.19 0.00% Jersey

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.